NEW YORK (GenomeWeb) – ImaBiotech and iTeos Therapeutics today announced that they have received a two-year €800,000 grant ($867,544) from the Walloon Region of Belgium and Bpifrance to fund research characterizing the microenvironment of tumor tissues.

Belgian therapeutics firm iTeos will contribute immune-oncology animal models and tissue libraries for metabolite profiling using ImaBiotech's Multimaging combined mass spectrometry imaging and immunohistology technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.